Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002527012 | SCV000754704 | pathogenic | Primary pulmonary hypertension | 2017-12-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys230Asnfs*22) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395). This variant has been reported in several individuals affected with pulmonary arterial hypertension (PMID: 10903931). This variant is also known as K230fsX21 in the literature. This variant is not present in population databases (ExAC no frequency). |
OMIM | RCV000488868 | SCV000029570 | pathogenic | Pulmonary hypertension, primary, 1 | 2000-09-01 | no assertion criteria provided | literature only | |
Rare Disease Genomics Group, |
RCV000488868 | SCV000576100 | pathogenic | Pulmonary hypertension, primary, 1 | no assertion criteria provided | literature only |